TY - JOUR
T1 - Electronic nicotine delivery system advertising in business-to-business publications, United States, 2015–2020
AU - Marynak, Kristy
AU - Welding, Kevin
AU - Kelley, Dannielle
AU - Trigger, Sarah
AU - Moran, Meghan B.
AU - Kennedy, Ryan D.
N1 - Funding Information:
Research reported in this publication was supported by the Center of Excellence in Regulatory Science and Innovation at Johns Hopkins University grant (5U01FD005942) from the Food and Drug Administration Center for Tobacco Products.
Publisher Copyright:
© 2022 Australasian Professional Society on Alcohol and other Drugs. This article has been contributed to by U.S. Government employees and their work is in the public domain in the USA.
PY - 2023/2
Y1 - 2023/2
N2 - Introduction: Tobacco retailers are a key target audience for tobacco product advertising, yet little is known about the messages and channels used to market electronic nicotine delivery systems (ENDS) to retailers. Methods: We assessed expenditures for business-to-business print advertising for ENDS in the United States, by year and by advertiser, from 2015 to 2020; and the content of advertisements placed in 2020. Results: The total number of ENDS brands placing business-to-business advertisements declined from 45 in 2015 to 6 in 2020; spending declined from $2.6 million in 2015 (for 283 occurrences) to $492,789 in 2020 (69 occurrences). Across years, the top-spending advertisers were Logic ($1.9 million), blu ($1.0 million), JUUL ($625,050), NJOY ($373,126) and Vuse ($322,075). Common messages of advertisements placed in 2020 included that products are not intended for minors; brand market share; health warnings; profitability or revenue potential for retailers; and flavours. Discussion: This study suggests that ENDS companies anticipate that ENDS retailers are interested in stocking products that maximise profits, appeal to consumers and comply with regulatory requirements. Declines in the number of advertisers mirror the overall consolidation of the ENDS industry that occurred during the study period. Conclusions: Business-to-business print advertising represents an important channel in which ENDS brands communicate a variety of messages about their products directly to potential retailers.
AB - Introduction: Tobacco retailers are a key target audience for tobacco product advertising, yet little is known about the messages and channels used to market electronic nicotine delivery systems (ENDS) to retailers. Methods: We assessed expenditures for business-to-business print advertising for ENDS in the United States, by year and by advertiser, from 2015 to 2020; and the content of advertisements placed in 2020. Results: The total number of ENDS brands placing business-to-business advertisements declined from 45 in 2015 to 6 in 2020; spending declined from $2.6 million in 2015 (for 283 occurrences) to $492,789 in 2020 (69 occurrences). Across years, the top-spending advertisers were Logic ($1.9 million), blu ($1.0 million), JUUL ($625,050), NJOY ($373,126) and Vuse ($322,075). Common messages of advertisements placed in 2020 included that products are not intended for minors; brand market share; health warnings; profitability or revenue potential for retailers; and flavours. Discussion: This study suggests that ENDS companies anticipate that ENDS retailers are interested in stocking products that maximise profits, appeal to consumers and comply with regulatory requirements. Declines in the number of advertisers mirror the overall consolidation of the ENDS industry that occurred during the study period. Conclusions: Business-to-business print advertising represents an important channel in which ENDS brands communicate a variety of messages about their products directly to potential retailers.
UR - http://www.scopus.com/inward/record.url?scp=85140236335&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85140236335&partnerID=8YFLogxK
U2 - 10.1111/dar.13558
DO - 10.1111/dar.13558
M3 - Article
C2 - 36269112
AN - SCOPUS:85140236335
SN - 0959-5236
VL - 42
SP - 262
EP - 267
JO - Drug and Alcohol Review
JF - Drug and Alcohol Review
IS - 2
ER -